AML1-ETO downregulates the granulocytic differentiation factor C/EBPα in t(8;21) myeloid leukemia

Nature Medicine

Volumn 7, Issue 4, 2001, Pages 444-451

  Pabst, Thomas ^a   Mueller, Beatrice U ^a   Harakawa, Nari ^a   Schoch, Claudia ^b   Haferlach, Torsten ^b   Behre, Gerhard ^b   Hiddemann, Wolfgang ^b   Zhang, Dong Er ^c   Tenen, Daniel G ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; CD14 ANTIGEN; CD34 ANTIGEN; HYBRID PROTEIN; TRANSCRIPTION FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; AUTOREGULATION; BLAST CELL; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; DNA BINDING; DOWN REGULATION; GRANULOCYTE; HUMAN; HUMAN CELL; KARYOTYPE; KNOCKOUT MOUSE; MYELOID LEUKEMIA; NEUTROPHIL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BASE SEQUENCE; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL DIFFERENTIATION; CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, PAIR 8; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DNA PRIMERS; DNA-BINDING PROTEINS; DOWN-REGULATION; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MICE; ONCOGENE PROTEINS, FUSION; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; RNA, MESSENGER; RNA, NEOPLASM; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 0035047652     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/86515     Document Type: Article

References (45)

1. Tissue-specific expression, developmental regulation, and genetic mapping of the gene encoding CCAAT/enhancer binding protein
2. Regulated expression of three C/EBP-isoforms during adipose conversion of 3T3-L1 cells
3. A novel temporal expression pattern of three C/EBP-family members in differentiating myelomonocytic cells
4. Increased hepatic cell proliferation and lung abnormalities in mice deficient in CCAAT/enhancer binding protein alpha
5. Cell lineage-specific and differentiation-dependent patterns of CCAAT/enhancer binding protein α expression in the gut epithelium of normal and transgenic mice
6. Transcription factor C/EBPα: Novel sites of expression and cloning of the human gene
7. Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein α-deficient mice
8. CCAAT/enhancer binding protein α is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors
9. C/EBPα bypasses granulocyte-stimulating factor signals to rapidly induce PU.1 gene expression, stimulate granulocytic differentiation, and limit proliferation in 32D cl3 myeloblasts
10. Dominant negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia
11. Biallelic and heterozygous point mutations in the Runt domain of the AML1/PEBP2αB gene associated with myeloblastic leukemias
12. Detection of DNA rearrangements in the AML1 and ETO loci and of an AML1/ETO fusion mRNA in patients with t(8;21) acute myeloid leukemia
13. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukemia
14. Identification of breakpoint in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt
15. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript
16. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis
17. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene AML1
18. The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B
19. PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2β/CBF β proto-oncoproteins, regulates the murine myeloperoxidease and neutrophil elastase genes in immature myeloid cells
20. CCAAT enhancer-binding protein (C/EBP) and AML1 (CBFα2) synergistically activate the macrophage colony-stimulating factor receptor promoter
21. Multiple functional domains of AML1: PU.1 and C/EBPα synergize with different regions of AML1
22. Identification of a region which directs the monocytic activity of the colony-stimulating factor 1 (macrophage colony-stimulating factor) receptor promoter and binds PEBP2/CBF (AML1)
23. Synergistic up-regulation of the myeloid-specific promoter for the macrophage colony-stimulating factor receptor by AML1 and the t(8;21) fusion protein may contribute to leukemogenesis
24. Embryonic lethality and impairment of hematopoiesis in mice heterozygous for an AML1-ETO fusion gene
25. The AML1/ETO fusion protein activates transcription of BCL-2
26. The t(8;21) fusion protein, AML1/ETO transforms NIH3T3 cells and activates AP-1
27. Analysis of the role of AML1-ETO in leukemogenesis using an inducible transgenic mouse model
28. The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation
29. The t(8;21) fusion product, AML-1-ETO, associates with C/EBPα, inhibits C/EBPα-dependent transcription, and blocks granulocytic differentiation
30. Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation
31. Establishment and characterization of a human histiocytic lymphoma cell line (U-937)
32. PU.1 (Spi-1) and C/EBPα regulate the granulocyte colony-stimulating factor receptor promoter in myeloid cells
33. Autoregulation of the human C/EBPα gene by stimulation of upstream stimulatory factor binding
34. CCAAT/enhancer binding protein gene promoter: Binding of nuclear factors during differentiation of 3T3-L1 preadipocytes
35. High level activity of the mouse CCAAT/enhancer binding protein (C/EBPα) gene promoter involves autoregulation and several ubiquitous transcription factors
36. Chromosomal translocations in human cancer
37. Transcription factors, normal myeloid development, and leukemia
38. AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation
39. Repressive effect of Sp1 on the C/EBPα gene promoter: Role in adipocyte differentiation
40. Derepression of the C/EBPα gene during adipogenesis: Identification of AP-2α as a repressor
41. A novel function for Myc: Inhibition of C/EBP-dependent gene activation
42. mRNA expression of the immunosuppressive cytokine IL-10 in human gliomas
43. Comparative detection and quantitation of human CDK inhibitor mRNA expression of p15INK4B, p16β, p18INK4C, p19INK4D, p21WAF1, p27KIP1 and p57KIP2 by RTPCR using a polycompetitive internal standard
44. Luciferase reporter gene vectors for analysis of promoters and enhancers
45. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters